The Potential of Stem Cell Models for Safety Testing
Dr. Glyn Stacey, Director of the UK Stem Cell Bank, offers some insights into the Bank’s work to support the development of stem cell models for safety testing. Pharma IQ: First, please can you outline the remit of the UK Stem Cell Bank and its relationship with the industry? G Stacey: To deliver ethically sourced and quality-controlled stocks of human stem cell lines to the research community and for use in translational research and clinical applications. The Bank is expected to operate with...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.